论文部分内容阅读
从抗病毒角度对抗HBV药物进行研究是临床上迫切需要解决的问题。但因临床动物模型十分困难,组织培养未成功,对研究造成一定限制。我们利用对DNAP阳性血清体外抑制实验及对HBV-DNA降解实验研究药物抗HBV作用。以磷羧基甲酸钠(PFA)
To study the anti-HBV drug against hepatitis B virus is an urgent problem to be solved clinically. However, due to the very difficult clinical animal model, tissue culture was unsuccessful, which caused some limitations on the research. We use DNAP-positive serum in vitro inhibition experiments and HBV-DNA degradation experiments to study the anti-HBV effect of drugs. Phosphocarboxylate (PFA)